v3.26.1
Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($)
$ in Millions
Jun. 30, 2026
Dec. 31, 2025
Investment securities, fair value $ 1,587 $ 1,532
Investment securities, amortized cost basis 1,652 1,584
Net finance receivables 25,145 24,833
Financing receivable, allowance for credit loss 2,923 2,865
Restricted cash and restricted cash equivalents 738 699
Long-term debt 22,769 22,694
Other liabilities $ 704 $ 682
Common stock, par value (in dollars per share) $ 0.01 $ 0.01
Common stock, shares authorized (in shares) 2,000,000,000 2,000,000,000
Common stock, shares issued (in shares) 115,082,807 117,196,792
Common stock, shares outstanding (in shares) 115,082,807 117,196,792
Treasury stock at cost (in shares) 20,954,574 18,514,904
Consolidated VIEs    
Net finance receivables $ 14,081 $ 13,418
Financing receivable, allowance for credit loss 1,635 1,558
Restricted cash and restricted cash equivalents 724 690
Long-term debt 11,953 11,464
Other liabilities $ 31 $ 30